NCT07207421Completed
The Effect of Ultra-Fast-Track Cardiac Anesthesia in Coronary Artery Bypass Grafting Surgery
Source: ClinicalTrials.gov · Last updated 10 Feb 2026
Brief summary (registry, in English)
This randomized controlled trial aims to evaluate the impact of Ultra-Fast-Track (UFT) anesthesia on postoperative recovery in patients undergoing elective coronary artery bypass grafting (CABG). UFT anesthesia targets extubation in the operating room or within the first hour after surgery, whereas standard care involves transfer to the intensive care unit (ICU) with subsequent extubation according to routine protocols. A total of 100 patients will be randomized in a 1:1 ratio. The primary outcome is the maximum Vaso-Inotropic Score (VIS) within the first 24 postoperative hours. Secondary outcomes include postoperative pain scores (VAS), Quality of Recovery-15 (QoR-15) scores, opioid and analgesic requirements, ICU and hospital length of stay, time to mobilization, and postoperative complications. This study seeks to determine whether UFT anesthesia can safely reduce inotropic support requirements and enhance early recovery following CABG.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 100 (actual)
- First submitted
- 19 Sept 2025
- Start date
- 1 Oct 2025
- Primary completion date
- 15 Dec 2025
- Lead sponsor
- Adiyaman University Research Hospital
- Diseases
- Coronary artery disease
- NCT number
- NCT07207421
What you commit to
- Study type: Interventional
- Participants enrolled: 100
- From 1 Oct 2025 to the primary completion date, 15 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Emergency CABG or combined cardiac procedures (e.g., valve surgery)
- Severe pulmonary disease (e.g., GOLD stage 3-4 COPD, home oxygen therapy)
- Severe hepatic failure or end-stage renal disease requiring dialysis
Other
- Preoperative shock or requirement for mechanical ventilation
- Pregnancy
- Inability to provide informed consent or follow-up
Who the study is looking for
- Adults aged ≥18 years undergoing elective coronary artery bypass grafting (CABG)
- Patients suitable for Ultra-Fast-Track anesthesia as determined by the anesthesia team
- Ability to provide written informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Adıyaman University Training and Research Hospital Coordinator of this site? Confirm its status | Adıyaman | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.